((4-(2-Methoxyphenoxy)phenyl)sulfonyl)glycine, 97%, 250mg

(3-Fluoro-6-methylpyridin-2-yl)methanamine hydrochloride, 97%, 100mg

Acido 5-cloro-2-nitrobenzoico, minimo 98%, per sintesi, 25 g, confezione in plastica.

4-Iodobenzaldehyde, 98.0%, 5g

2-Chloro-5-fluoronicotinamide, 95.0%, 100mg

potassium {1-[(tert-butoxy)carbonyl]piperidin-4-yl}trifluoroboranuide, 95, 25g

2-(1H-imidazol-1-yl)-1-phenylethanone, 95.0%, 1g

2-Chloro-4-fluorobenzamide, 97.0%, 1g

2-methylimidazo[1,2-a]pyridine-8-carboxylic acid dihydrochloride hydrate, 95.0%, 10g

(S)-(1-Methylpiperidin-3-yl)methanamine dihydrochloride, 95.0%, 500mg

4-BROMO-2-FLUORO-6-METHYLBENZAMIDE, 95.0%, 1g

3-Benzyl-3-azabicyclo[3.1.0]hexane-2,4-dione, 95.0%, 5g

(S)-4-ISOPROPYL-2-(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 1g